Prosus

PRX · Euronext Amsterdam · EUR

€34.81Change from previous close: −1.98%Absolute change: −€0.71

Close · October 1, 2026

At a glance

Revenue growth
+57.29%
FY to Mar 2026 vs FY to Mar 2025
Net income growth
−5.89%
FY to Mar 2026 vs FY to Mar 2025
Net margin
119.9%
FY to Mar 2025: 200.4%

Financial data

Amounts in millions of USD; per-share values in USD; shares in millions.

Income statement · Annual
ItemFY to Mar 2026FY to Mar 2025FY to Mar 2024FY to Mar 2023FY to Mar 2022
Total revenue9,7056,1705,4674,947—
Cost of revenue5,1983,5463,2453,310—
Gross profit4,5072,6242,2221,637—
Selling, general and administrative4,2032,4632,3882,023—
Operating income304161-166-386—
EBIT12,42313,2227,57810,310—
EBITDA12,94713,3687,74810,479—
Interest expense645549557553—
Pre-tax income11,77812,6737,0219,757—
Income tax11717916142.0—
Net income11,63812,3676,60610,112—
Net income to common shareholders11,63812,3676,60610,112—
Basic EPS—5.142.553.685.70
Diluted EPS—5.112.533.635.65
Average shares (basic)—2,4052,5932,7503,284
Average shares (diluted)—2,4052,5932,7503,284